Primary Multiple Malignant Peripheral Nerve Sheath Tumors with Hematogenous and Lymphatic Metastases in Neurofibromatosis Type 1: A Case Report

Cover Page

Cite item

Full Text

Abstract

Introduction. Malignant peripheral nerve sheath tumor (MPNST) is a neuroectodermal sarcoma with an incidence of 5−9 %. Approximately 25−50 % of MPNST cases are associated with neurofibromatosis type 1 (NF1). Case Description. A patient presented to the Oncology Research Institute at the Tomsk National Medical Research Center in 2009 with a painless mass on the posterior right thigh. Diagnostic evaluation confirmed a grade 2 MPNST of the soft tissues. The patient underwent wide local excision with intraoperative radiation therapy (12 Gy). Clinical findings — including multiple neurofibromas along the sciatic nerve and café-au-lait spots — established a diagnosis of NF1. Local recurrence occurred three years postoperatively, requiringre-excision with IORT (15 Gy). In 2014, a solitary lung metastasis was resected via atypical lower lobectomy, followed by adjuvant chemotherapy. One year later, the patient presented with gastric bleeding secondary to a new tumor, requiring gastrectomy with D2 lymphadenectomy. Histopathological examination revealed a multinodular conglomerate extensively involving the gastric wall with serosal extension (without adjacent organ invasion) and metastatic perigastric lymph node involvement, consistent with metachronous grade 3 MPNST with metastatic involvement of one lymph node. Disease progression manifested as peritoneal metastases and ascites in January 2016, leading to patient mortality two months later. Conclusion. MPNST associated with NF1 represents a rare, highly aggressive malignancy with poor prognosis. Key characteristics include high local recurrence rates and metastatic potential via both hematogenous and lymphatic pathways.

About the authors

Evgeniy O. Rodionov

Cancer Research Institute, Tomsk National Research Medical Center, Russian Academy of Sciences; Siberian State Medical University of the Ministry of Health of Russia

Email: rodionov_eo@oncology.tomsk.ru
ORCID iD: 0000-0003-4980-8986
SPIN-code: 7650-2129
Scopus Author ID: 57189622130
ResearcherId: B-7280-2017
Tomsk, the Russian Federation; Tomsk, the Russian Federation

Nikolay V. Vasiliev

Cancer Research Institute, Tomsk National Research Medical Center, Russian Academy of Sciences

Email: rodionov_eo@oncology.tomsk.ru
ORCID iD: 0000-0002-4066-2688
SPIN-code: D-1144-2012
Scopus Author ID: 57192110276
ResearcherId: D-1144-2012
Tomsk, the Russian Federation

Sergey V. Miller

Cancer Research Institute, Tomsk National Research Medical Center, Russian Academy of Sciences

Email: rodionov_eo@oncology.tomsk.ru
ORCID iD: 0000-0002-5365-9840
SPIN-code: 6510-9849
Scopus Author ID: 56525429400
ResearcherId: C-8970-2012
Tomsk, the Russian Federation

Vera M. Kolmakova

Siberian State Medical University of the Ministry of Health of Russia

Email: rodionov_eo@oncology.tomsk.ru
ORCID iD: 0009-0000-0159-3432
SPIN-code: MGW-5351-2025
Tomsk, the Russian Federation

References

  1. Васильев Н.В. Лимфогенное метастазирование сарком мягких тканей: частота метастазирования, факторы риска, механизмы возникновения. Сибирский онкологический журнал. 2015; 1(3): 68-75.-URL: https://www.siboncoj.ru/jour/article/view/217/219. [Vasilyev N.V. Lymph node metastasis from soft tissue sarcomas: incidence of metastatic spread, risk factors, mechanisms of occurrence. Siberian Journal of Oncology. 2015; 1(3): 68-75.-URL: https://www.siboncoj.ru/jour/article/view/217/219 (In Rus)].
  2. Васильев Н.В., Коцюрбий Е.А., Санникова А.В., et al. Злокачественная опухоль из оболочек периферических нервов: феномен дивергентной дифференцировки. Обзор литературы. Вопросы онкологии. 2025; 71(1): 45-53.-DOI: https://doi.org/10.37469/0507-3758-2025-71-1-OF-2244. [Nikolay V. Vasilyev, Evgeniy A. Kotsyur-biy, Aleksandra V. Sannikova, et al. A malignant peripheral nerve sheath tumor: the phenomenon of divergent differentiation. Literature review. Voprosy Onkologii = Problems in Oncology. 2025; 71(1): 45-53. (In Rus).-DOI: https://doi.org/10.37469/0507-3758-2025-71-1-OF-2244 (In Rus)].
  3. Yao C., Zhou H., Dong Y., et al. Malignant peripheral nerve sheath tumors: latest concepts in disease pathogenesis and clinical management. Cancers (Basel). 2023; 15(4): 1077.-DOI: https://doi.org/10.3390/cancers15041077. URL: https://pubmed.ncbi.nlm.nih.gov/36831419/.
  4. Goldblum J.R., Folpe A.L., Weiss S.W. Enzinger & Weiss’s Soft Tissue Tumors. 7th ed. Philadelphia, PA: Elsevier. 2020: 1294.
  5. Thway K., Fisher C. Malignant peripheral nerve sheath tumor: pathology and genetics. Ann Diagn Pathol. 2014; 18(2): 109-116.-DOI: https://doi.org/10.1016/j.anndiagpath.2013.10.007.-URL: https://pubmed.ncbi.nlm.nih.gov/24418643/.
  6. Jiang C., McKay R.M., Le L.Q. Tumorigenesis in neurofibromatosis type 1: role of the microenvironment. Oncogene. 2021; 40(39): 5781-5787.-DOI: https://doi.org/10.1038/s41388-021-01979-z.-URL: https://pubmed.ncbi.nlm.nih.gov/34345017/.
  7. Lee T.S.J., Chopra M., Kim R.H., et al. Incidence and prevalence of neurofibromatosis type 1 and 2: a systematic review and meta-analysis. Orphanet J Rare Dis. 2023; 18(1): 292.-DOI: https://doi.org/10.1186/s13023-023-02911-2.-URL: https://pubmed.ncbi.nlm.nih.gov/37710322/.
  8. Legius E., Messiaen L., Wolkenstein P., et al. Revised diagnostic criteria for neurofibromatosis type 1 and Legius syndrome: an international consensus recommendation. Genet Med. 2021; 19: 1-8.-DOI: https://doi.org/10.1038/s41436-021-01170-5. URL: https://pubmed.ncbi.nlm.nih.gov/34012067/.
  9. Somatilaka B.N., Sadek A., McKay R.M., Le L.Q. Malignant peripheral nerve sheath tumor: models, biology, and translation. Oncogene. 2022; 41(17): 2405-2421.-DOI: https://doi.org/10.1038/s41388-022-02290-1. URL: https://pubmed.ncbi.nlm.nih.gov/35393544/.
  10. WHO Classification of Tumours Editorial Board. Soft tissue and bone tumours. 5th ed. Vol. 3. Lyon: International Agency for Research on Cancer; 2020.
  11. Stucky C.C., Johnson K.N., Gray R.J., et al. Malignant peripheral nerve sheath tumors (MPNST): the Mayo Clinic experience. Ann Surg Oncol. 2012; 19(3): 878-885.-DOI: https://doi.org/10.1245/s10434-011-1978-7.-URL: https://pubmed.ncbi.nlm.nih.gov/21861229/.
  12. Kim E.Y., Lee S.H., Yoo H.M., et al. Gastric malignant peripheral nerve sheath tumor: a case report. Int J Surg Pathol. 2015; 23(6): 505-508.-DOI: https://doi.org/10.1177/1066896915573570. URL: https://pubmed.ncbi.nlm.nih.gov/25796444/.
  13. Hwang H.S., Jeong Y.J., Nam K.H., et al. Gastric malignant peripheral nerve sheath tumor in type 1 neurofibromatosis. Korean J Gastroenterol. 2022; 79(6): 265-269.-DOI: https://doi.org/10.4166/kjg.2022.022. URL: https://pubmed.ncbi.nlm.nih.gov/35746841/.
  14. Cui W., Xing L., Fu L., et al. Primary malignant peripheral nerve sheath tumor of the stomach: a rare case report and review of literature. Int J Surg Pathol. 2023; 31(2): 221-226.-DOI: https://doi.org/10.1177/10668969221098094.-URL: https://pubmed.ncbi.nlm.nih.gov/35491655/.
  15. Godfrey G.J., Farghaly H. Lymph node metastasis of malignant peripheral nerve sheath tumor in the absence of widespread disease five years after diagnosis: a rare finding. Int J Clin Exp Pathol. 2010; 3(8): 812-4.-URL: https://pubmed.ncbi.nlm.nih.gov/21151396/.

Supplementary files

Supplementary Files
Action
1. JATS XML

Copyright (c) 2025 Problems in Oncology

Согласие на обработку персональных данных

 

Используя сайт https://journals.rcsi.science, я (далее – «Пользователь» или «Субъект персональных данных») даю согласие на обработку персональных данных на этом сайте (текст Согласия) и на обработку персональных данных с помощью сервиса «Яндекс.Метрика» (текст Согласия).